Indolo[2,3-a]carbazoles: diversity, biological properties, application in antitumor therapy

[Figure not available: see fulltext.] This review presents the history of the discovery of indolo[2,3-a]carbazoles, lists the currently known natural compounds of this subclass, and gives the sources for their isolation. The main approaches used to obtain synthetic indolo[2,3-a]carbazoles are described, and examples of compounds from this group that are most promising because of their high antitumor activity are given. The spectrum of biological properties of natural and synthetic compounds of this subclass is highlighted. The molecular mechanisms of their antitumor action as the most significant in the context of clinical use are separately considered. Particular attention is paid to indolo[2,3-a]- carbazoles that have reached clinical trials or are already in use for the treatment of malignant neoplasms. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.

Authors
Zenkov R.G.1 , Ektova L.V.1 , Vlasova O.А.1 , Belitskiy G.А.1 , Yakubovskaya M.G.1 , Kirsanov K.I. 1, 2
Publisher
Латвийский институт органического синтеза Латвийской академии наук / Springer New York Consultants Bureau
Number of issue
6
Language
English
Pages
644-658
Status
Published
Volume
56
Year
2020
Organizations
  • 1 N. N. Blokhin Russian Cancer Research Center, 24 Kashirskoe shosse, Moscow, 115478, Russian Federation
  • 2 RUDN University, 6 Miklukho-Maklaya St., Moscow, 117198, Russian Federation
Keywords
antitumor activity; indolocarbazoles; indolo[2,3-a]carbazoles; rebeccamycin; staurosporine
Date of creation
02.11.2020
Date of change
02.11.2020
Short link
https://repository.rudn.ru/en/records/article/record/64669/
Share

Other records